Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neehar D Parikh

Showing results (81-90 of 267) with videos related to

Pageof 27
Sort By:
Journal of Community Health|March 9, 2013
A colorectal cancer screening program in an underserved, ethnically diverse population in Chicago, ILAndrew J Gawron, Barbara Jung, Angela J Fought, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 19, 2022
Development and Implementation of a Hepatocellular Carcinoma Surveillance Quality MetricNeehar D Parikh, Cheryl Dehmlow, Tammy Ellies, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2022
Clinical Outcomes of Patients With Suspicious (LI-RADS 4) Liver ObservationsKristeen Onyirioha, Sagar Joshi, Daniel Burkholder, et al.
Journal of Hepatology|April 3, 2022
Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United StatesElliot B Tapper, Utibe R Essien, Zhe Zhao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver ObservationsAshwini Arvind, Sagar Joshi, Timothy Zaki, et al.
Hepatology Communications|June 4, 2020
Comprehensive Health-State Utilities in Contemporary Patients With CirrhosisChelsey Foster, Jad Baki, Samantha Nikirk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2018
Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?Daniel R Wahl, Matthew J Schipper, Neehar D Parikh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2020
Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic ReviewVincent L Chen, Dabo Xu, Max S Wicha, et al.
Journal of Hepatocellular Carcinoma|May 20, 2025
The Real-World Prevalence of Esophagogastric Varices, Bleeding, Emergency Room Visits, and Hospitalization Among Patients with Advanced Hepatocellular Carcinoma in the United States: A Retrospective Cohort StudyNeehar D Parikh, Noh Jin Park, Michael Locker, et al.
Digestive Diseases and Sciences|March 15, 2022
Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018Azaan Ramani, Elliot B Tapper, Connor Griffin, et al.
Pageof 27

Showing results (81-90 of 267) with videos related to

Sort By:
Pageof 27
Journal of Community Health|March 9, 2013
A colorectal cancer screening program in an underserved, ethnically diverse population in Chicago, ILAndrew J Gawron, Barbara Jung, Angela J Fought, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 19, 2022
Development and Implementation of a Hepatocellular Carcinoma Surveillance Quality MetricNeehar D Parikh, Cheryl Dehmlow, Tammy Ellies, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2022
Clinical Outcomes of Patients With Suspicious (LI-RADS 4) Liver ObservationsKristeen Onyirioha, Sagar Joshi, Daniel Burkholder, et al.
Journal of Hepatology|April 3, 2022
Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United StatesElliot B Tapper, Utibe R Essien, Zhe Zhao, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 13, 2021
Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver ObservationsAshwini Arvind, Sagar Joshi, Timothy Zaki, et al.
Hepatology Communications|June 4, 2020
Comprehensive Health-State Utilities in Contemporary Patients With CirrhosisChelsey Foster, Jad Baki, Samantha Nikirk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2018
Casual Causality: Does Radiofrequency Ablation Really Prolong Survival After Treatment of Localized Hepatocellular Carcinoma?Daniel R Wahl, Matthew J Schipper, Neehar D Parikh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2020
Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic ReviewVincent L Chen, Dabo Xu, Max S Wicha, et al.
Journal of Hepatocellular Carcinoma|May 20, 2025
The Real-World Prevalence of Esophagogastric Varices, Bleeding, Emergency Room Visits, and Hospitalization Among Patients with Advanced Hepatocellular Carcinoma in the United States: A Retrospective Cohort StudyNeehar D Parikh, Noh Jin Park, Michael Locker, et al.
Digestive Diseases and Sciences|March 15, 2022
Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018Azaan Ramani, Elliot B Tapper, Connor Griffin, et al.
Pageof 27